3,379
Views
75
CrossRef citations to date
0
Altmetric
Original Article

Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential

, , , &
Pages 599-612 | Received 07 Jan 2011, Accepted 23 Jun 2011, Published online: 18 Oct 2011

References

  • Arsenault, W.G., Boothe, D.M., Gordon, S.G., Miller, M.W., Chalkley, J.R., Petrikovics, I. (2005). Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs. American J Vet Res. 66:2172–6.
  • Bogaard, H.J., Natarajan, R., Mizuno, S., Abbate, A., Chang, P.J., Chau, V.Q., Hoke, N.N., Kraskauskas, D., Kasper, M., Salloum, F.N., Voelkel, N.F. (2010). Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med. 182:652–60.
  • Charman, S.A., Charman, W.N., Rogge, M.C., Wilson, T.D., Dutko, F.J., Pouton, C.W. (1992). Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 9:87–93.
  • Constantinides, P.P., Wasan, K.M. (2007). Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: In vitro/in vivo case studies. J Pharm Sci. 96:235–48.
  • Craig, D.Q.M., Barker, S.A., Banning, D., Booth, S.W. (1995). An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 114:103–10.
  • Cui, S.X., Nie, S.F., Li, L., Wang, C.G., Pan, W.S., Sun, J.P. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 35:603–11.
  • de Smidt, P.C., Campanero, M.A., Troconiz, I.F. (2004). Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm. 270:109–18.
  • Elnaggar, Y.S., El-Massik, M.A., Abdallah, O.Y. (2009). Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm. 380:133–41.
  • Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., Li, Y. (2011). Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. J Control Release. 149:168–74.
  • Gupta, H., Bhandari, D., Sharma, A. (2009). Recent trends in oral drug delivery: A review. Recent Pat Drug Deliv Formul. 3:162–73.
  • Hauss, D.J. (2007). Oral lipid-based formulations: Enhancing the bioavailability of poorly water-soluble drugs, drugs and the pharmaceutical sciences. 1st ed. Vol 170. New York: Informa Healthcare USA, Inc.
  • Ho, Y.F., Lai, M.Y., Yu, H.Y., Huang, D.K., Hsueh, W.C., Tsai, T.H., Lin, C.C. (2008). Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates. J Formos Med Assoc. 107:37–45.
  • Hokama, N., Hobara, N., Kameya, H., Ohshiro, S., Sakanashi, M. (1999). Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 732:233–8.
  • http://www.ich.org/cache/compo/363-272-1.html, accessed 12 December 2010.
  • http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2_Guideline.pdf, accessed 25 December 2010.
  • http://www.reportlinker.com/p0189377/Innovations-in-Oral-Solid-Drug-Delivery-Advances-in-nanotechnology-controlled-formulations-peptide-delivery.html, accessed 24 December 2010.
  • http://www.who.int/topics/cardiovascular_diseases/en/, accessed 20 December 2010.
  • Humberstone, A.J., Charman, W.N. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 25:103–28.
  • Joshi, M., Pathak, S., Sharma, S., Patravale, V. (2008). Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. Int J Pharm. 362:172–8.
  • Koga, K., Kusawake, Y., Ito, Y., Sugioka, N., Shibata, N., Takada, K. (2006). Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate. Eur J Pharm Biopharm. 64:82–91.
  • Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm. 212:233–46.
  • Laia, C.A.T., López-Cornejo, P., Costa, S.M.B., d’Oliveira, J., Martinho, J.M.G. (1998). Dynamic light scattering study of AOT microemulsions with nonaqueous polar additives in an oil continuous phase. Langmuir. 14:3531–7.
  • Morgan, T. (1994). Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 26:335–46.
  • Nielsen, F.S., Petersen, K.B., Müllertz, A. (2008). Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm. 69:553–62.
  • Patel, M., Tekade, A., Gattani, S., Surana, S. (2008). Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech. 9:1262–9.
  • Porter, C.J., Charman, W.N. (2001). Intestinal lymphatic drug transport: An update. Adv Drug Deliv Rev. 50:61–80.
  • Porter, C.J.H., Trevaskis, N.L., Charman, W.N. (2007). Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 6:231–48.
  • Pouton, C.W., Porter, C.J. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 60:625–37.
  • Sha, X., Yan, G., Wu, Y., Li, J., Fang, X. (2005). Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 24:477–86.
  • Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R.K., Ali, M. (2007). Formulation development and optimization using nanoemulsion technique: A technical note. AAPS PharmSciTech 8:E1–E6
  • Singh, B., Ahuja, N. (2002). Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm. 28:431–42.
  • Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., Katare, O. (2009b). Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 26:427–521.
  • Singh, B., Bandyopadhyay, S., Katare, O.P. (2009a). Book review on “Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs”. Drug Deliv. 16:125–6.
  • Singh, B., Chakkal, S.K., Ahuja, N. (2006). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech. 7:E3.
  • Singh, B., Dahiya, M., Saharan, V., Ahuja, N. (2005b). Optimizing drug delivery systems using systematic “design of experiments.” Part II: Retrospect and prospects. Crit Rev Ther Drug Carrier Syst. 22:215–94.
  • Singh, B., Kaur, T., Singh, S. (1997). Correction of raw dissolution data for loss of drug during sampling. Indian J Pharm Sci. 59:196–9.
  • Singh, B., Kumar, R., Ahuja, N. (2005a). Optimizing drug delivery systems using systematic “design of experiments.” Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst. 22:27–105.
  • Singh, B., Singh, S. (1998). A Comprehensive computer program for study of drug release kinetics from compressed matrices. Indian J Pharm Sci. 60:313–6.
  • Spernath, A., Aserin, A. (2006). Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci. 128–130, 47–64.
  • Thi, T.D., Van Speybroeck, M., Barillaro, V., Martens, J., Annaert, P., Augustijns, P., Van Humbeeck, J., Vermant, J., Van den Mooter, G. (2009). Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 38:479–88.
  • VCCLAB VCCL. (2005). Available online at: http://www.vcclab.org, accessed 22 December 2010.
  • Vogt, M., Kunath, K., Dressman, J.B. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 68:283–8.
  • von Mollendorff, E., Reiff, K., Neugebauer, G. (1987). Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clin Pharmacol. 33:511–3.
  • Wei, L., Sun, P., Nie, S., Pan, W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 31:785–94.
  • Wen, H., Jiang, H., Lu, Z., Hu, X., He, B., Tang, Q., Huang, C. (2010). Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats. Biomed Pharmacother. 64:446–50.
  • Yao, J., Lu, Y., Zhou, J.P. (2008). Preparation of nobiletin in self-microemulsifying systems and its intestinal permeability in rats. J Pharm Pharm Sci. 11:22–9.
  • Yavuz, B., Bilensoy, E., Vural, I., Sumnu, M. (2010). Alternative oral exemestane formulation: improved dissolution and permeation. Int J Pharm. 398:137–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.